Predicting the Clinical Advantages of Speaking Valves Through Wearable Devices
Recruiting
N/A
Interventional Study
Physiological Parameter
Wearable Devices
Tracheostomy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 120 (estimated)
- Sponsor
- Bin Zhang · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The population included in this study consists of tracheostomy patients admitted to the pulmonary department of Beijing Rehabilitation Hospital, undergoing decannulation rehabilitation treatment. Once patient conditions stabilized, they were all transitioned to the decannulation process established by our department in 2018, which utilizes a speaking valve instead of capping.The initial duration f…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 90 years≥Age≥18 years;
* Tracheotomy post-operation\>48 hours；
* Weaned off mechanical ventilation;
* Clinically stable condition;
* Tolerable for cuff deflation;
* Able to tolerate wearing a speaking valve continuously for 30 minutes;
* Signed informed consent.
Exclusion Cri…
Contacts